Amphista Therapeutics Limited vs Orum Therapeutics
Amphista Therapeutics Limited
A new approach to targeted protein degradation to bring life-changing medicines to patients
34 employees · est. 2017 · Cambridge, United Kingdom
Orum Therapeutics
A public biotechnology company pioneering a novel class of protein degraders
55 employees · est. 2016 · Lexington, United States
Orum Therapeutics is the older company (2017 vs 2016); Orum Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Amphista Therapeutics Limited | Orum Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2016 older |
| Headquarters | ||
| Headquarters | Cambridge, United Kingdom | Lexington, United States |
| Employees | ||
| Employees | 34 | 55 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series B | IPO |
| Total Funding | ||
| Total Funding | $60.50M | $330.75M |
| Funding Rounds | ||
| Funding Rounds | 3 | 7 |
| Services | ||
| Services | Development of next-generation targeted protein degradation therapeutics, Application of proprietary targeted glue technology, Research and development of transformational medicines | Drug Candidate Development, Pipeline Innovation, Protein Degrader Technology, Novel Drug Discovery |
| Target Customers | ||
| Target Customers | Pharmaceutical companies, Biotech firms, Research institutions, Healthcare providers | Healthcare Providers, Pharmaceutical Companies, Research Institutions, Investors |
| Taxonomy | ||
| Taxonomy | Targeted Protein DegradationBiopharmaceuticalsCancer TherapeuticsDisease ModulationProtein Degradation MechanismsDrug Discovery +9 | Clinical StageOncologyCancerProtein DegradationAntibody TherapyDrug Development +8 |
| Website | ||
| Website | amphista.com | orumrx.com |
About Amphista Therapeutics Limited
Amphista Therapeutics Limited is a pioneering biopharmaceutical company based in the United Kingdom that stands at the forefront of targeted protein degradation (TPD). The company's slogan, "A new approach to targeted protein degradation to bring life-changing medicines to patients," underscores its...
About Orum Therapeutics
Orum Therapeutics is a public biotechnology company known for pioneering a novel class of protein degraders. As a key player in Biotechnology and Health Care, it has introduced TPD2®, a breakthrough in targeted protein degradation therapeutics described as degrader-antibody conjugates (DACs). These...
Also comparing in this category
We will tell you when either one moves
BounceWatch watches Amphista Therapeutics Limited and Orum Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.
Get notified when Amphista Therapeutics Limited or Orum Therapeutics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Frequently Asked Questions
Compare Amphista Therapeutics Limited with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Amphista Therapeutics Limited on 15 Jun 2026, and Orum Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
